Literature DB >> 17546665

pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute.

Sung-Up Choi1, Tot Bui, Rodney J Y Ho.   

Abstract

We have investigated the ability of lipid-indinavir particles composed of 3-to-1 lipid-drug molar ratio to encapsulate an aqueous marker calcein and anti-HIV drug (3)H-phosphonylmethoxypropyl-adenine (PMPA). Even at a high density of indinavir associated to lipid-indinavir nanoparticles, they form an enclosed lipid membrane that allows encapsulation of calcein and PMPA in an aqueous compartment. At neutral pH, practically all indinavir was incorporated into lipid bilayer and lipid associated indinavir can be dissociated with half-maximum pH recorded between 5.2 and 5.5. pH-Dependent release of indinavir did not influence calcein release significantly. However, pH-dependent release of indinavir affected PMPA release. By lowering pH, PMPA release was enhanced in the presence of indinavir in the lipid bilayer. Collectively, these data indicate that indinavir incorporated in lipid particles provides (1) stable bilayers capable of encapsulating other hydrophilic drugs, (2) ability to dissociate indinavir (which is acid stable) from lipid membranes, by lowering the pH, and (3) enabling enhancement in pH-dependent release of aqueous contents. However, the degree of pH-dependent release could be related to the charge and size of an aqueous molecule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17546665     DOI: 10.1002/jps.21020

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine.

Authors:  Vivek Agrahari; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2012-01-04       Impact factor: 3.246

2.  AIDS treatment with novel anti-HIV compounds improved by nanotechnology.

Authors:  Xiaowei Ma; Dongliang Wang; Yan Wu; Rodney J Y Ho; Lee Jia; Peixuan Guo; Liming Hu; Gengmei Xing; Yi Zeng; Xing-Jie Liang
Journal:  AAPS J       Date:  2010-04-06       Impact factor: 4.009

3.  pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

Authors:  Tao Zhang; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Biopharm       Date:  2011-06-26       Impact factor: 5.571

4.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

5.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

6.  Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates.

Authors:  Jennifer P Freeling; Josefin Koehn; Cuiling Shu; Jianguo Sun; Rodney J Y Ho
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

7.  Design and characterization of novel peptide-coated lipid nanoparticles for targeting anti-HIV drug to CD4 expressing cells.

Authors:  Aaron N Endsley; Rodney J Y Ho
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

8.  Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

Authors:  John D Hoekman; Pramod Srivastava; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2014-06-06       Impact factor: 3.534

Review 9.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 10.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.